image
Inhibrx Biosciences, Inc. INBX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 13.83
-3.49 %
$ 200 M
Market Cap
0.12
P/E
CASH FLOW STATEMENT
-193 M OPERATING CASH FLOW
-67.66%
Growth Rates
1Year -67.66%
3Years -59.14%
5Years -52.95%
7Years -40.25%
10Years 0.00%
-4.59 M INVESTING CASH FLOW
-569.53%
Growth Rates
1Year -569.53%
3Years -49.89%
5Years -26.30%
7Years -54.86%
10Years 0.00%
202 M FINANCING CASH FLOW
-21.89%
Growth Rates
1Year -21.89%
3Years 6.66%
5Years 72.68%
7Years 32.10%
10Years 0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Inhibrx Biosciences, Inc.
image
Net Income -241 M
Depreciation & Amortization 1.19 M
Capital Expenditures -4.59 M
Stock-Based Compensation 24.8 M
Change in Working Capital 15.3 M
Others 20.4 M
Free Cash Flow -198 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
OPERATING CASH FLOW
Net Income (241.4) (145.2) (81.8) (76.1) (51.4) (31.0) (22.1) (8.3)
Depreciation & Amortization 1.2 1.2 1.2 1.0 1.2 0.7 0.4 0.3
Deferred Income Tax 0 0 9 K (2.1) 1.1 0 0 0
Stock Based Compensation 24.8 17.8 15.0 5.0 4.0 2.5 1.2 0.6
Other Operating Activities 6.7 5.1 2.7 11.6 9.6 0.5 0.7 (3.4)
Change in Working Capital 15.3 3.2 (17.5) 12.7 3.5 4.2 1.0 (6.3)
Cash From Operations (193.3) (115.3) (80.3) (48.0) (32.1) (23.1) (18.8) (18.1)
INVESTING CASH FLOW
Capital Expenditures (4.6) (0.7) (0.9) (1.4) (1.8) (1.4) (1.3) (0.2)
Other Items 0 0 55 K 0 0 0 0 0
Cash From Investing Activities (4.6) (0.7) (0.8) (1.4) (1.8) (1.4) (1.3) (0.2)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 0
Total Debt Repaid 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 (0.8) (1.4) 0
Other Financing Activities 202.0 128.8 83.8 166.5 43.3 14.0 14.9 28.8
Cash From Financing Activities 202.0 258.6 83.8 166.5 43.3 13.2 13.5 28.8
CHANGE IN CASH
Net Change In Cash 4.1 142.6 2.6 117.1 9.4 (11.4) (6.6) 10.4
FREE CASH FLOW
Free Cash Flow (197.9) (116.0) (81.2) (49.3) (33.9) (24.5) (20.1) (18.3)